Lumason infusion vs. bolus for better heart imaging
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two ways of giving Lumason (an ultrasound contrast agent) to improve images of the left ventricle in people whose initial heart ultrasound was unclear. It may help those with a 'suboptimal' view of the heart's pumping chamber.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- Your doctor performed a heart ultrasound (echocardiogram) and saw that at least two sections of the left lower chamber were not visible.
- You agree to follow the study schedule and sign a consent form.
- You do not have severe heart failure, uncontrolled chest pain, or a recent heart attack (within the last 3 days).
- You are not pregnant or breastfeeding, and you have not taken other contrast agents within 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people who have heart-related symptoms but do not have clear blocked heart arteries, using special heart imaging. It may help researchers better understand early forms of heart weakness (with preserved pumping function) and improve how these conditions are diagnosed.
This trial uses a special ultrasound with a contrast agent to get clearer images of breast lumps. It may help doctors decide if a lump needs a biopsy.
This trial tests a new contrast agent called NH002 that may help doctors see your heart more clearly on an ultrasound. It could be an option if your previous heart ultrasound images were not clear enough.
This trial uses a special ultrasound with contrast to study fluid on the brain (hydrocephalus) in newborn babies. The aim is to learn more about the condition and improve treatment options.
This trial checks whether a special ultrasound (with contrast) can help doctors evaluate blunt abdominal injuries in children. It may reduce the need for rushed decisions by improving how internal injuries are seen quickly and safely.
This trial tests if lumacaftor, a medication used in cystic fibrosis, can improve blood flow to the brain in people with stable heart failure. It might help if you have heart failure with reduced pumping function and low brain blood flow.
Hear when a new Heart Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.